TipRanks
Go Ultimate55% OFF

Spencer Pharmaceutical (SPPH) Financial Statements

Spencer Pharmaceutical Financial Overview

Spencer Pharmaceutical's market cap is currently $294. The company's EPS TTM is ―; its P/E ratio is 0.00; Spencer Pharmaceutical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 03Dec 02Dec 01
Income Statement
Total Revenue―――
Gross Profit―――
Operating Income$ -862.54K$ -2.28M$ -2.24M
EBITDA$ -862.54K$ -2.23M$ -1.01M
Net Income$ -862.54K$ -2.24M$ -2.23M
Balance Sheet
Cash & Short-Term Investments―――
Total Assets$ 4.24M$ 419.24K$ 1.96M
Total Debt$ 154.26K$ 0.00$ 0.00
Net Debt$ 133.18K$ -304.18K$ -1.48M
Total Liabilities$ 379.64K$ 839.39K$ 1.68M
Stockholders' Equity―――
Cash Flow
Free Cash Flow$ -769.51K$ -2.68M$ 114.35K
Operating Cash Flow―――
Investing Cash Flow―――
Financing Cash Flow―――

Currency in USD